CRS | CERES Regulatory Services

CAR-T Cell Therapy in the FDA Spotlight

1 BKi5QWc zoM2NqpaMl1mhA

CAR-T Cell Therapy in the FDA Spotlight. FDA mandated boxed warnings for CAR-T cell therapies, this followed a 28 November 2023 communication that FDA was “Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies,” and a July — September 2023 Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event […]

Unveiling the Potential of Cell and Gene Therapy in Modern Healthcare

100

  Introduction: In the ever-evolving landscape of healthcare, two essential components take center stage—Drugs and Biologics, with Cell and Gene Therapy at the forefront. These remarkable advancements are not just therapeutic agents; they represent the cutting edge of medical science, offering innovative solutions to a myriad of health challenges. Join us on a journey as […]

The Heartfelt Journey with Advanced Tissue Products

89

Introduction:In the intricate tapestry of healthcare, hope often comes in unexpected forms. Advanced Tissue Products stand as a testament to the compassion and innovation that weave together to redefine the healing journey. Join us on a heartfelt exploration of the profound impact these cutting-edge marvels are having on the lives of individuals, offering not just […]

Unleashing the Power of Cell Therapy

Innovative Strategic Regulatory Services Designed to Achieve First Cycle Approvals & Rescue from Regulatory Challenges

Introduction: In the realm of medical advancements, cell therapy stands as a beacon of hope, offering a revolutionary approach to healing that transcends traditional treatment methods. This groundbreaking field harnesses the body’s own cellular power to combat diseases and promote regeneration. Join us on a journey through the wonders of cell therapy and discover how […]

error: Content is protected !!